These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 23044773
1. Sensitive spectrofluorimetric determination of tizanidine in pharmaceutical preparations, human plasma and urine through derivatization with dansyl chloride. Ulu ST. Luminescence; 2012; 27(5):426-30. PubMed ID: 23044773 [Abstract] [Full Text] [Related]
2. Highly sensitive spectrofluorimetric determination of lomefloxacin in spiked human plasma, urine and pharmaceutical preparations. Ulu ST. Eur J Med Chem; 2009 Sep; 44(9):3402-5. PubMed ID: 19359067 [Abstract] [Full Text] [Related]
3. Determination of bupropion using liquid chromatography with fluorescence detection in pharmaceutical preparations, human plasma and human urine. Ulu ST, Tuncel M. J Chromatogr Sci; 2012 May; 50(5):433-9. PubMed ID: 22454390 [Abstract] [Full Text] [Related]
4. Validated spectrofluorimetric method for the determination of tamsulosin in spiked human urine, pure and pharmaceutical preparations. Karasakal A, Ulu ST. Luminescence; 2014 May; 29(3):239-42. PubMed ID: 23847119 [Abstract] [Full Text] [Related]
5. Spectrofluorimetric determination of nomifensine in human plasma and urine by derivatization with fluorescamine. Ulu ST. Luminescence; 2012 May; 27(1):80-3. PubMed ID: 21681914 [Abstract] [Full Text] [Related]
6. Development and validation of a sensitive spectrofluorimetric method for the determination of amoxapine in human plasma and urine. Karasakal A, Ulu ST. Luminescence; 2014 May; 29(3):284-7. PubMed ID: 23780763 [Abstract] [Full Text] [Related]
7. Spectrofluorimetric determination of oxamniquine in dosage forms and spiked human plasma through derivatization with 1-dimethylaminonaphthalene-5-sulphonyl chloride. El-Enany N, Belal F, Rizk M. J Fluoresc; 2008 Mar; 18(2):349-55. PubMed ID: 18058206 [Abstract] [Full Text] [Related]
8. Spectrophotometric and spectrofluorimetric determination of atomoxetine in pharmaceutical preparations. Ulu ST. Pharmazie; 2011 Nov; 66(11):831-5. PubMed ID: 22204127 [Abstract] [Full Text] [Related]
9. Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o-phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samples. Walash MI, Belal F, El-Enany N, El-Maghrabey MH. Luminescence; 2012 Nov; 27(6):511-8. PubMed ID: 22362604 [Abstract] [Full Text] [Related]
10. Spectrofluorimetric method for the determination of sulpiride in pharmaceutical preparations and human plasma through derivatization with 2-cyanoacetamide. Shah J, Jan MR, Khan MN, Shah S. Luminescence; 2013 Nov; 28(5):719-25. PubMed ID: 22987788 [Abstract] [Full Text] [Related]
11. Spectrofluorimetric determination of tobramycin in human serum and pharmaceutical preparations by derivatization with fluorescamine. Tekkeli SE, Önal A, Sağırlı AO. Luminescence; 2014 Feb; 29(1):87-91. PubMed ID: 23520194 [Abstract] [Full Text] [Related]
12. Simple and sensitive spectrofluorimetric method for the determination of pregabalin in capsules through derivatization with fluorescamine. Walash MI, Belal F, El-Enany N, El-Maghrabey MH. Luminescence; 2011 Feb; 26(5):342-8. PubMed ID: 20737649 [Abstract] [Full Text] [Related]
13. Development and validation of a spectrofluorimetric method for the quantification of ceftriaxone in pharmaceutical formulations and plasma. Shah J, Jan MR, Shah S, Inayatullah. Luminescence; 2013 Feb; 28(4):516-22. PubMed ID: 23436454 [Abstract] [Full Text] [Related]
14. Spectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl chloride. Aydoğmuş Z, Sarı F, Ulu ST. J Fluoresc; 2012 Mar; 22(2):549-56. PubMed ID: 21953437 [Abstract] [Full Text] [Related]
15. A novel spectrofluorimetric method for the assay of pseudoephedrine hydrochloride in pharmaceutical formulations via derivatization with 4-chloro-7-nitrobenzofurazan. El-Didamony AM, Gouda AA. Luminescence; 2011 Mar; 26(6):510-7. PubMed ID: 22162453 [Abstract] [Full Text] [Related]
16. Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations. Ulu ST. Spectrochim Acta A Mol Biomol Spectrosc; 2009 Feb; 72(1):138-43. PubMed ID: 18977686 [Abstract] [Full Text] [Related]
17. Spectrofluorimetric determination of aliskiren in dosage forms and urine. Aydoğmuş Z. Luminescence; 2012 Feb; 27(6):489-94. PubMed ID: 22290775 [Abstract] [Full Text] [Related]
18. Highly sensitive spectrofluorimetric method for determination of doxazosin through derivatization with fluorescamine; Application to content uniformity testing. Omar MA, Hammad MA, Salman BI, Derayea SM. Spectrochim Acta A Mol Biomol Spectrosc; 2016 Mar 15; 157():55-60. PubMed ID: 26716887 [Abstract] [Full Text] [Related]
19. New spectrofluorimetric method for determination of cephalosporins in pharmaceutical formulations. Ali Ahmed SM, Elbashir AA, Suliman FE, Aboul-Enein HY. Luminescence; 2013 Mar 15; 28(5):734-41. PubMed ID: 22991324 [Abstract] [Full Text] [Related]
20. Validated spectrofluorimetric method for determination of two phosphodiesterase inhibitors tadalafil and vardenafil in pharmaceutical preparations and spiked human plasma. Abu El-Enin MA, Al-Ghaffar Hammouda Mel-S, El-Sherbiny DT, El-Wasseef DR, El-Ashry SM. Luminescence; 2016 Feb 15; 31(1):173-8. PubMed ID: 26019060 [Abstract] [Full Text] [Related] Page: [Next] [New Search]